Kinetic modeling of human induced pluripotent stem cell expansion in suspension culture

To date, practical application of mathematical models for model-based design of stem cell expansion processes is limited. Nevertheless, the first attempts show vast potential of this approach for the improvement of expansion process performance. This article presents the developed dynamic kinetic model of the human induced pluripotent stem cell expansion process in suspension culture. The model predicts cell growth, consumption of glucose and production of lactic acid, as well as the average aggregate size. The latter process variable is of particular importance for achieving high cell density. By adding botulinum hemagglutinin, an E-cadherin inhibitor and subsequent aggregate break-up, one can significantly increase performance of cell expansion process. After defining the appropriate optimization criteria and additional modification of the model, the latter can be further applied for model-based optimization of the final cell concentration by calculating optimal aggregate break-up and glucose/glutamine feeding strategies.

[1]  Jincheng Wu,et al.  Oxygen Transport and Stem Cell Aggregation in Stirred-Suspension Bioreactor Cultures , 2014, PloS one.

[2]  Masahiro Kino-oka,et al.  Culture medium refinement by dialysis for the expansion of human induced pluripotent stem cells in suspension culture , 2016, Bioprocess and Biosystems Engineering.

[3]  Robert Zweigerdt,et al.  Impact of Feeding Strategies on the Scalable Expansion of Human Pluripotent Stem Cells in Single‐Use Stirred Tank Bioreactors , 2016, Stem cells translational medicine.

[4]  R. McKay,et al.  Human pluripotent stem cell culture: considerations for maintenance, expansion, and therapeutics. , 2014, Cell stem cell.

[5]  R. Simutis,et al.  Current state and perspectives in modeling and control of human pluripotent stem cell expansion processes in stirred‐tank bioreactors , 2017, Biotechnology progress.

[6]  Y. Fujinaga,et al.  Functional Dissection of the Clostridium botulinum Type B Hemagglutinin Complex: Identification of the Carbohydrate and E-Cadherin Binding Sites , 2014, PloS one.

[7]  S. Agathos,et al.  Process engineering of stem cell metabolism for large scale expansion and differentiation in bioreactors , 2014 .

[8]  Yan Li,et al.  Stem cell engineering in bioreactors for large‐scale bioprocessing , 2014 .

[9]  G. Forde,et al.  Model-based analysis and optimization of bioreactor for hematopoietic stem cell cultivation , 2011, Bioprocess and biosystems engineering.

[10]  Maria Margarida Diogo,et al.  Stem cell cultivation in bioreactors. , 2011, Biotechnology advances.

[11]  Suman C. Nath,et al.  Botulinum hemagglutinin‐mediated in situ break‐up of human induced pluripotent stem cell aggregates for high‐density suspension culture , 2018, Biotechnology and bioengineering.

[12]  A. Khademhosseini,et al.  Population balance modelling of stem cell culture in 3D suspension bioreactors , 2015 .

[13]  Suzanne S Farid,et al.  Human pluripotent stem cell-derived products: Advances towards robust, scalable and cost-effective manufacturing strategies , 2014, Biotechnology journal.

[14]  S. Yamanaka Induced pluripotent stem cells: past, present, and future. , 2012, Cell stem cell.

[15]  Catarina Brito,et al.  Process engineering of human pluripotent stem cells for clinical application. , 2012, Trends in biotechnology.

[16]  H. Baharvand,et al.  Bioprocess development for mass production of size-controlled human pluripotent stem cell aggregates in stirred suspension bioreactor. , 2012, Tissue engineering. Part C, Methods.

[17]  Efstratios N. Pistikopoulos,et al.  Improving Embryonic Stem Cell Expansion through the Combination of Perfusion and Bioprocess Model Design , 2013, PloS one.

[18]  Vincent C. Chen,et al.  The suspension culture of undifferentiated human pluripotent stem cells using spinner flasks. , 2015, Methods in molecular biology.

[19]  Robert Zweigerdt,et al.  Suspension culture of human pluripotent stem cells in controlled, stirred bioreactors. , 2012, Tissue engineering. Part C, Methods.

[20]  Robert Zweigerdt,et al.  Controlling Expansion and Cardiomyogenic Differentiation of Human Pluripotent Stem Cells in Scalable Suspension Culture , 2014, Stem cell reports.